Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1986 Sep;54(3):439–446. doi: 10.1038/bjc.1986.195

Plasma lipids and prolactin in patients with breast cancer.

I A Bani, C M Williams, P S Boulter, J W Dickerson
PMCID: PMC2001617  PMID: 3756079

Abstract

In a comparative study of pre- and postmenopausal women with benign and malignant breast disease, a number of differences were observed in circulating plasma prolactin and lipid concentrations. Plasma lipids, phospholipids, triglycerides, cholesterol and free fatty acids were all higher in blood obtained from breast cancer patients prior to surgery. HDL-Cholesterol levels were significantly lower in these patients. These differences remained when the patient groups were sub-divided according to menopausal status. Plasma prolactin concentrations were also found to be higher in cancer compared with non-cancer patients, this effect being more marked in premenopausal than in postmenopausal patients. Premenopausal patients with invasive or poorly differentiated disease had significantly higher prolactin levels than those with non-invasive disease. No correlations were found between plasma prolactin and any of the lipid fractions.

Full text

PDF
441

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. K., Hensley W. J., Nicholls A. V., Whitfield J. B. An enzymic and centrifugal method for estimating high-density lipoprotein cholesterol. Clin Chem. 1979 Feb;25(2):325–327. [PubMed] [Google Scholar]
  2. Basu T. K., Williams D. C. Plasma and body lipids in patients with carcinoma of the breast. Oncology. 1975;31(3-4):172–176. doi: 10.1159/000225022. [DOI] [PubMed] [Google Scholar]
  3. Berridge M. J. Inositol trisphosphate and diacylglycerol as second messengers. Biochem J. 1984 Jun 1;220(2):345–360. doi: 10.1042/bj2200345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boyns A. R., Cole E. N., Griffiths K., Roberts M. M., Buchan R., Wilson R. G., Forrest A. P. Plasma prolactin in breast cancer. Eur J Cancer. 1973 Feb;9(2):99–102. doi: 10.1016/0014-2964(73)90078-9. [DOI] [PubMed] [Google Scholar]
  5. Carroll K. K. Experimental evidence of dietary factors and hormone-dependent cancers. Cancer Res. 1975 Nov;35(11 Pt 2):3374–3383. [PubMed] [Google Scholar]
  6. Carroll K. K., Khor H. T. Dietary fat in relation to tumorigenesis. Prog Biochem Pharmacol. 1975;10:308–353. [PubMed] [Google Scholar]
  7. Cave W. T., Jr, Dunn J. T., MacLeod R. M. Effects of iodine deficiency and high-fat diet on N-nitrosomethylurea-induced mammary cancers in rats. Cancer Res. 1979 Mar;39(3):729–734. [PubMed] [Google Scholar]
  8. Cave W. T., Jr, Erickson-Lucas M. J. Effects of dietary lipids on lactogenic hormone receptor binding in rat mammary tumors. J Natl Cancer Inst. 1982 Feb;68(2):319–324. [PubMed] [Google Scholar]
  9. Chan P. C., Cohen L. A. Effect of dietary fat, antiestrogen, and antiprolactin on the development of mammary tumors in rats. J Natl Cancer Inst. 1974 Jan;52(1):25–30. doi: 10.1093/jnci/52.1.25. [DOI] [PubMed] [Google Scholar]
  10. Chan P. C., Dao T. L. Enhancement of mammary carcinogenesis by a high-fat diet in Fischer, Long-Evans, and Sprague-Dawley rats. Cancer Res. 1981 Jan;41(1):164–167. [PubMed] [Google Scholar]
  11. Cole E. N., England P. C., Sellwood R. A., Griffiths K. Serum prolactin concentrations throughout the menstrual cycle of normal women and patients with recent breast cancer. Eur J Cancer. 1977 Jul;13(7):677–684. doi: 10.1016/0014-2964(77)90053-6. [DOI] [PubMed] [Google Scholar]
  12. DUNCOMBE W. G. THE COLORIMETRIC MICRO-DETERMINATION OF NON-ESTERIFIED FATTY ACIDS IN PLASMA. Clin Chim Acta. 1964 Feb;9:122–125. doi: 10.1016/0009-8981(64)90004-x. [DOI] [PubMed] [Google Scholar]
  13. Elsair J., Denine R. Action de la prolactine de mouton sur le taux des acides gras libres du plasma et sur la glycémie de l'enfant normal à jeun. Rev Eur Etud Clin Biol. 1970 Oct;15(8):899–905. [PubMed] [Google Scholar]
  14. Feldman E. B., Carter A. C. Circulating lipids and lipoproteins in women with metastatic breast carcinoma. J Clin Endocrinol Metab. 1971 Jul;33(1):8–13. doi: 10.1210/jcem-33-1-8. [DOI] [PubMed] [Google Scholar]
  15. Fishman J., Fukushima D., O'Connor J., Rosenfeld R. S., Lynch H. T., Lynch J. F., Guirgis H., Maloney K. Plasma hormone profiles of young women at risk for familial breast cancer. Cancer Res. 1978 Nov;38(11 Pt 2):4006–4011. [PubMed] [Google Scholar]
  16. Gottfried S. P., Rosenberg B. Improved manual spectrophotometric procedure for determination of serum triglycerides. Clin Chem. 1973 Sep;19(9):1077–1078. [PubMed] [Google Scholar]
  17. Graham S., Marshall J., Mettlin C., Rzepka T., Nemoto T., Byers T. Diet in the epidemiology of breast cancer. Am J Epidemiol. 1982 Jul;116(1):68–75. doi: 10.1093/oxfordjournals.aje.a113403. [DOI] [PubMed] [Google Scholar]
  18. Greenberg E. R., Vessey M. P., McPherson K., Doll R., Yeates D. Body size and survival in premenopausal breast cancer. Br J Cancer. 1985 May;51(5):691–697. doi: 10.1038/bjc.1985.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gregorio D. I., Emrich L. J., Graham S., Marshall J. R., Nemoto T. Dietary fat consumption and survival among women with breast cancer. J Natl Cancer Inst. 1985 Jul;75(1):37–41. [PubMed] [Google Scholar]
  20. HAMID M. A., RUBINSTEIN K. A., FERGUSON K. A., BECK J. C. THE EFFECT OF GROWTH HORMONE AND PROLACTIN PREPARATIONS ON THE INTERMEDIARY METABOLISM OF RAT ADIPOSE TISSUE. Biochim Biophys Acta. 1965 Apr 12;100:179–192. doi: 10.1016/0304-4165(65)90440-x. [DOI] [PubMed] [Google Scholar]
  21. Henderson B. R., Gerkins V., Rosario I., Casagrande J., Pike M. C. Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer. N Engl J Med. 1975 Oct 16;293(16):790–795. doi: 10.1056/NEJM197510162931602. [DOI] [PubMed] [Google Scholar]
  22. Hill P., Garbaczewski L., Helman P., Huskisson J., Sporangisa E., Wynder E. L. Diet, lifestyle, and menstrual activity. Am J Clin Nutr. 1980 Jun;33(6):1192–1198. doi: 10.1093/ajcn/33.6.1192. [DOI] [PubMed] [Google Scholar]
  23. Hill P., Wynder E. L., Kumar H., Helman P., Rona G., Kuno K. Prolactin levels in populations at risk for breast cancer. Cancer Res. 1976 Nov;36(11 Pt 1):4102–4106. [PubMed] [Google Scholar]
  24. Kwa H. G., Wang D. Y. An abnormal luteal-phase evening peak of plasma prolactin in women with a family history of breast cancer. Int J Cancer. 1977 Jul 15;20(1):12–14. doi: 10.1002/ijc.2910200104. [DOI] [PubMed] [Google Scholar]
  25. Lea A. J. Dietary factors associated with death-rates from certain neoplasms in man. Lancet. 1966 Aug 6;2(7458):332–333. doi: 10.1016/s0140-6736(66)92615-8. [DOI] [PubMed] [Google Scholar]
  26. Levin P. A., Malarkey W. B. Daughters of women with breast cancer have elevated mean 24-hour prolactin (PRL) levels and a partial resistance of PRL to dopamine suppression. J Clin Endocrinol Metab. 1981 Jul;53(1):179–183. doi: 10.1210/jcem-53-1-179. [DOI] [PubMed] [Google Scholar]
  27. Lubin F., Ruder A. M., Wax Y., Modan B. Overweight and changes in weight throughout adult life in breast cancer etiology. A case-control study. Am J Epidemiol. 1985 Oct;122(4):579–588. doi: 10.1093/oxfordjournals.aje.a114137. [DOI] [PubMed] [Google Scholar]
  28. MacLeod R. M., Bass M. B., Huang S. C., Smith M. C. Intermediary metabolism in the liver and adipose tissue of rats with hormone-secreting pituitary tumors. Endocrinology. 1968 Feb;82(2):253–265. doi: 10.1210/endo-82-2-253. [DOI] [PubMed] [Google Scholar]
  29. Malarkey W. B., Schroeder L. L., Stevens V. C., James A. G., Lanese R. R. Disordered nocturnal prolactin regulation in women with breast cancer. Cancer Res. 1977 Dec;37(12):4650–4654. [PubMed] [Google Scholar]
  30. McNamara J. J., Molot M., Dunn R., Burran E. L., Stremple J. F. Lipid metabolism after trauma. Role in the pathogenesis of fat embolism. J Thorac Cardiovasc Surg. 1972 Jun;63(6):968–972. [PubMed] [Google Scholar]
  31. Meites J. Relation of prolactin and estrogen to mammary tumorigenesis in the rat. J Natl Cancer Inst. 1972 Apr;48(4):1217–1224. [PubMed] [Google Scholar]
  32. Miller A. B., Kelly A., Choi N. W., Matthews V., Morgan R. W., Munan L., Burch J. D., Feather J., Howe G. R., Jain M. A study of diet and breast cancer. Am J Epidemiol. 1978 Jun;107(6):499–509. doi: 10.1093/oxfordjournals.aje.a112569. [DOI] [PubMed] [Google Scholar]
  33. Moore D. H., Moore D. H., 2nd, Moore C. T. Breast carcinoma etiological factors. Adv Cancer Res. 1983;40:189–253. doi: 10.1016/s0065-230x(08)60681-8. [DOI] [PubMed] [Google Scholar]
  34. Naito H. K. Modification of the Fiske and SubbaRow method for total phospholipid in serum. Clin Chem. 1975 Sep;21(10):1454–1456. [PubMed] [Google Scholar]
  35. Noel G. L., Suh H. K., Stone J. G., Frantz A. G. Human prolactin and growth hormone release during surgery and other conditions of stress. J Clin Endocrinol Metab. 1972 Dec;35(6):840–851. doi: 10.1210/jcem-35-6-840. [DOI] [PubMed] [Google Scholar]
  36. Nomura A., Henderson B. E., Lee J. Breast cancer and diet among the Japanese in Hawaii. Am J Clin Nutr. 1978 Nov;31(11):2020–2025. doi: 10.1093/ajcn/31.11.2020. [DOI] [PubMed] [Google Scholar]
  37. Ohgo S., Kato Y., Chihara K., Imura H. Plasma prolactin responses to thyrotropin-releasing hormone in patients with breast cancer. Cancer. 1976 Mar;37(3):1412–1416. doi: 10.1002/1097-0142(197603)37:3<1412::aid-cncr2820370323>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  38. Rolandi E., Barreca T., Masturzo P., Polleri A., Indiveri F., Barabino A. Letter: Plasma-prolactin in breast cancer. Lancet. 1974 Oct 5;2(7884):845–846. doi: 10.1016/s0140-6736(74)91115-5. [DOI] [PubMed] [Google Scholar]
  39. Rudel L. L., Morris M. D. Determination of cholesterol using o-phthalaldehyde. J Lipid Res. 1973 May;14(3):364–366. [PubMed] [Google Scholar]
  40. Sheth N. A., Ranadive K. J., Suraiya J. N., Sheth A. R. Circulating levels of prolactin in human breast cancer. Br J Cancer. 1975 Aug;32(2):160–167. doi: 10.1038/bjc.1975.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Spiegel R. J., Schaefer E. J., Magrath I. T., Edwards B. K. Plasma lipid alterations in leukemia and lymphoma. Am J Med. 1982 May;72(5):775–782. doi: 10.1016/0002-9343(82)90543-5. [DOI] [PubMed] [Google Scholar]
  42. Tarquini A., di Martino L., Malloci A., Kwa H. G., van der Gugten A. A., Bulbrook R. D., Wang D. Y. Abnormalities in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease. Int J Cancer. 1978 Dec;22(6):687–690. doi: 10.1002/ijc.2910220608. [DOI] [PubMed] [Google Scholar]
  43. Tartter P. I., Papatestas A. E., Ioannovich J., Mulvihill M. N., Lesnick G., Aufses A. H., Jr Cholesterol and obesity as prognostic factors in breast cancer. Cancer. 1981 May 1;47(9):2222–2227. doi: 10.1002/1097-0142(19810501)47:9<2222::aid-cncr2820470919>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  44. WYNDER E. L., BROSS I. J., HIRAYAMA T. A study of the epidemiology of cancer of the breast. Cancer. 1960 May-Jun;13:559–601. doi: 10.1002/1097-0142(196005/06)13:3<559::aid-cncr2820130322>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  45. Wallace R. B., Rost C., Burmeister L. F., Pomrehn P. R. Cancer incidence in humans: relationship to plasma lipids and relative weight. J Natl Cancer Inst. 1982 Jun;68(6):915–918. [PubMed] [Google Scholar]
  46. Wood C. B., Habib N. A., Thompson A., Bradpiece H., Smadja C., Hershman M., Barker W., Apostolov K. Increase of oleic acid in erythrocytes associated with malignancies. Br Med J (Clin Res Ed) 1985 Jul 20;291(6489):163–165. doi: 10.1136/bmj.291.6489.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Yanai R., Nagasawa H. Inhibition by ergocornine and 2-Br-alpha-ergocryptin of spontaneous mammary tumor appearance in mice. Experientia. 1971 Aug;27(8):934–935. doi: 10.1007/BF02135754. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES